Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results

Fig. 1

Marked reduction of treatment-naïve polyp after 6 months of intravitreal aflibercept. a. EPIC study baseline ICG angiogram (left) with correlated OCT study (right). Note the hyperfluorescent polyp with hypofluorescent ring on ICG angiogram. On the OCT, an inverted U-shaped polyp (arrow) is seen with surrounding serous detachment. b. ICG angiogram (left) following 6 months of intravitreal aflibercept with corresponding OCT (right) reveals marked reduction in the polyp (arrow)

Back to article page